Sacubitril (49mg), Valsartan (51mg)
Feb 03, 2023
SACUBRIGHT 100
Sacubitril (49mg), Valsartan (51mg)
Sacubitril/valsartan, the first angiotensin receptor neprilysin inhibitor approved by the Food and Drug Administration for marketing, has been shown to reduce the risk of cardiovascular death or heart failure hospitalization and improve symptoms in patients with chronic heart failure with a reduced ejection fraction.
For further information please contact: info@sterispharma.com
Recent Post
Effective Diabetes Management: Glibenclamide (5mg) + Metformin HCl (500mg) for Blood Sugar Control
Essential Amino Acids: The Building Blocks for a Healthy Body
Silodosin 4mg: How It Works for Enlarged Prostate & Urinary Flow Improvement
Everything You Need to Know About Mycophenolate Mofetil 250mg Tablets
Cholestyramine Resin 4gm: Effective Cholesterol-Lowering & Bile Acid Sequestrant
Ranolazine 1000mg Tablets: The Ultimate Guide for Patients
Divalproex ER (250mg) – A Safe and Effective Medication for Seizure Control and Mental Health
Lisinopril 5mg Tablet – Complete Guide to Blood Pressure Management
Piroxicam Dispersible 20mg – A Trusted NSAID for Arthritis & Pain Management
Nimodipine BP 30mg – Mechanism of Action, Safety, and Effectiveness